SLN Financial Statements

Balance sheet, income statement, cash flow, and dividends for Silence Therapeutics Plc (SLN).


$324.83M Market Cap.

As of 02/28/2025 5:00 PM ET (MRY) • Disclaimer

SLN Market Cap. (MRY)


SLN Shares Outstanding (MRY)


SLN Assets (MRY)


Total Assets

$202.63M

Total Liabilities

$68.61M

Total Investments

$26.00M

SLN Income (MRY)


Revenue

$43.26M

Net Income

-$45.31M

Operating Expense

$94.77M

SLN Cash Flow (MRY)


CF Operations

-$67.64M

CF Investing

-$21.97M

CF Financing

$142.09M

SLN Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

-

-

2022

$0

0%

0%

-

-

2021

$0

0%

0%

-

-

2020

$0

0%

-

-

-

SLN Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$202,635,000 (115.98%)

$93,822,000 (-2.96%)

$96,686,000 (0.51%)

$96,194,000 (11.89%)

Assets Current

$187,366,000 (131.26%)

$81,021,000 (23.74%)

$65,476,000 (-24.16%)

$86,333,000 (13.00%)

Assets Non-Current

$15,269,000 (19.28%)

$12,801,000 (18.37%)

$10,814,000 (9.66%)

$9,861,000 (3.02%)

Goodwill & Intangible Assets

$9,704,000 (19.45%)

$8,124,000 (-2.46%)

$8,329,000 (9.36%)

$7,616,000 (-6.46%)

Shareholders Equity

-$134,023,000 (-886.06%)

$17,050,000 (-22.75%)

$22,072,000 (158.88%)

$8,526,000 (-5.88%)

Property Plant & Equipment Net

$1,975,000 (8.94%)

$1,813,000 (-17.63%)

$2,201,000 (13.22%)

$1,944,000 (72.49%)

Cash & Equivalents

$121,330,000 (124.56%)

$54,031,000 (-1.43%)

$54,816,000 (-25.46%)

$73,537,000 (167.90%)

Accumulated Other Comprehensive Income

$11,781,000 (503.84%)

$1,951,000 (-6.43%)

$2,085,000 (35.30%)

$1,541,000 (-30.52%)

Deferred Revenue

$52,096,000 (-18.69%)

$64,071,000 (-11.44%)

$72,349,000 (-5.73%)

$76,748,000 (12.24%)

Total Investments

$26,004,000 (9056.34%)

$284,000 (-98.26%)

$16,328,000 (5324.58%)

$301,000 (-97.08%)

Investments Current

$26,004,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$284,000 (0.00%)

$284,000 (-5.65%)

$301,000 (-0.66%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$972,000 (326.32%)

$228,000 (-75.08%)

$915,000 (176.44%)

$331,000 (-98.87%)

Trade & Non-Trade Payables

$16,399,000 (31.94%)

$12,429,000 (-1.61%)

$12,633,000 (17.16%)

$10,783,000 (31.63%)

Accumulated Retained Earnings (Deficit)

$474,044,000 (255.62%)

-$304,612,000 (-15.71%)

-$263,263,000 (-18.07%)

-$222,966,000 (-21.04%)

Tax Assets

$0 (0%)

$17,627,000 (18.45%)

$14,882,000 (114.28%)

$6,945,000 (96.41%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$117,000 (-56.99%)

$272,000 (-39.01%)

$446,000 (225.55%)

$137,000 (-59.82%)

Debt Current

$117,000 (-34.64%)

$179,000 (-59.87%)

$446,000 (225.55%)

$137,000 (-59.82%)

Debt Non-Current

$0 (0%)

$93,000 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$68,612,000 (-10.63%)

$76,772,000 (2.89%)

$74,614,000 (-14.89%)

$87,668,000 (13.98%)

Liabilities Current

$16,822,000 (-5.33%)

$17,769,000 (-19.02%)

$21,943,000 (44.68%)

$15,167,000 (-40.70%)

Liabilities Non-Current

$51,790,000 (-12.22%)

$59,003,000 (-7.06%)

$63,485,000 (-12.44%)

$72,501,000 (41.23%)

SLN Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$43,258,000 (70.47%)

$25,375,000 (44.99%)

$17,501,000 (40.97%)

$12,415,000 (126.59%)

Cost of Revenue

$11,810,000 (14.46%)

$10,318,000 (-5.17%)

$10,880,000 (45.92%)

$7,456,000 (98.19%)

Selling General & Administrative Expense

$26,884,000 (30.28%)

$20,636,000 (5.24%)

$19,609,000 (-1.99%)

$20,008,000 (43.09%)

Research & Development Expense

$67,883,000 (54.19%)

$44,025,000 (23.65%)

$35,605,000 (15.73%)

$30,765,000 (52.23%)

Operating Expenses

$94,767,000 (46.56%)

$64,661,000 (17.11%)

$55,214,000 (8.75%)

$50,773,000 (35.16%)

Interest Expense

$0 (0%)

$2,152,000 (4478.72%)

$47,000 (-9.62%)

$52,000 (-83.90%)

Income Tax Expense

$845,000 (112.00%)

-$7,043,000 (-2.38%)

-$6,879,000 (-6.72%)

-$6,446,000 (-84.49%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$45,309,000 (-4.72%)

-$43,267,000 (-6.86%)

-$40,489,000 (-2.74%)

-$39,410,000 (-21.09%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$45,309,000 (-4.72%)

-$43,267,000 (-6.86%)

-$40,489,000 (-2.74%)

-$39,410,000 (-21.09%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$45,309,000 (-4.72%)

-$43,267,000 (-6.86%)

-$40,489,000 (-2.74%)

-$39,410,000 (-21.09%)

Weighted Average Shares

$138,752,224 (19.60%)

$116,009,788 (7.74%)

$107,680,012 (19.94%)

$89,777,000 (14.55%)

Weighted Average Shares Diluted

$138,752,224

-

-

-

Earning Before Interest & Taxes (EBIT)

-$44,464,000 (7.67%)

-$48,158,000 (-1.77%)

-$47,321,000 (-3.31%)

-$45,804,000 (-28.24%)

Gross Profit

$31,448,000 (108.86%)

$15,057,000 (127.41%)

$6,621,000 (33.51%)

$4,959,000 (188.82%)

Operating Income

-$63,319,000 (-27.65%)

-$49,604,000 (-2.08%)

-$48,593,000 (-6.07%)

-$45,814,000 (-27.80%)

SLN Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$21,966,000 (-233.69%)

$16,430,000 (199.32%)

-$16,542,000 (-290.66%)

$8,676,000 (-9.79%)

Net Cash Flow from Financing

$142,087,000 (464.85%)

$25,155,000 (-41.57%)

$43,049,000 (40.17%)

$30,711,000 (99.06%)

Net Cash Flow from Operations

-$67,640,000 (-71.89%)

-$39,350,000 (13.43%)

-$45,456,000 (-767.88%)

$6,806,000 (163.16%)

Net Cash Flow / Change in Cash & Cash Equivalents

$52,481,000 (2248.14%)

$2,235,000 (111.79%)

-$18,949,000 (-141.02%)

$46,193,000 (223.71%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$21,755,000 (-240.20%)

$15,517,000 (196.23%)

-$16,125,000 (-261.25%)

$10,000,000 (0.00%)

Capital Expenditure

-$211,000 (-368.89%)

-$45,000 (67.86%)

-$140,000 (89.32%)

-$1,311,000 (-158.07%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$174,000 (8.42%)

-$190,000 (9.95%)

-$211,000 (47.51%)

Issuance (Purchase) of Equity Shares

$142,087,000 (460.97%)

$25,329,000 (-41.42%)

$43,239,000 (39.83%)

$30,922,000 (95.34%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$60,000 (101.99%)

-$3,020,000 (-1424.56%)

$228,000 (317.14%)

-$105,000 (68.75%)

Share Based Compensation

$16,307,000 (24.96%)

$13,050,000 (27.29%)

$10,252,000 (18.77%)

$8,632,000 (96.41%)

Depreciation Amortization & Accretion

$593,000 (28.35%)

$462,000 (-3.35%)

$478,000 (16.30%)

$411,000 (-13.66%)

SLN Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

72.70% (22.60%)

59.30% (56.88%)

37.80% (-5.26%)

39.90% (27.48%)

Profit Margin

-104.70% (38.59%)

-170.50% (26.32%)

-231.40% (27.10%)

-317.40% (46.57%)

EBITDA Margin

-101.40% (46.06%)

-188.00% (29.77%)

-267.70% (26.78%)

-365.60% (43.16%)

Return on Average Equity (ROAE)

-64.80% (75.32%)

-262.60% (10.10%)

-292.10% (34.83%)

-448.20% (-106.35%)

Return on Average Assets (ROAA)

-20.30% (56.81%)

-47.00% (-13.53%)

-41.40% (4.39%)

-43.30% (12.17%)

Return on Sales (ROS)

-102.80% (45.84%)

-189.80% (29.81%)

-270.40% (26.70%)

-368.90% (43.41%)

Return on Invested Capital (ROIC)

-59.40% (76.93%)

-257.50% (70.94%)

-886.20% (-143.39%)

-364.10% (-106.99%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-6.95

-

-

-

Price to Sales Ratio (P/S)

7.36 (-64.82%)

20.91 (-19.44%)

25.96 (-39.89%)

43.19 (-43.60%)

Price to Book Ratio (P/B)

-2.42 (-107.79%)

31.12 (51.20%)

20.58 (-67.27%)

62.89 (35.79%)

Debt to Equity Ratio (D/E)

-0.51 (-111.37%)

4.5 (33.22%)

3.38 (-67.13%)

10.28 (21.11%)

Earnings Per Share (EPS)

-0.99

-

-

-

Sales Per Share (SPS)

0.94 (12.52%)

0.83 (41.57%)

0.59 (6.15%)

0.55 (92.68%)

Free Cash Flow Per Share (FCFPS)

-1.47 (-43.96%)

-1.02 (19.76%)

-1.27 (-790.22%)

0.18 (142.59%)

Book Value Per Share (BVPS)

-2.9 (-757.14%)

0.44 (-28.29%)

0.61 (115.79%)

0.28 (-17.87%)

Tangible Assets Book Value Per Share (TABVPS)

4.17 (88.22%)

2.22 (-9.99%)

2.46 (-16.82%)

2.96 (-0.64%)

Enterprise Value Over EBIT (EV/EBIT)

-6 (40.00%)

-10 (-25.00%)

-8 (20.00%)

-10 (9.09%)

Enterprise Value Over EBITDA (EV/EBITDA)

-5.64 (43.08%)

-9.91 (-26.23%)

-7.85 (23.31%)

-10.24 (11.94%)

Asset Turnover

0.19 (-29.45%)

0.28 (53.63%)

0.18 (31.62%)

0.14 (63.86%)

Current Ratio

11.14 (144.25%)

4.56 (52.82%)

2.98 (-47.58%)

5.69 (90.56%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$67,851,000 (-72.23%)

-$39,395,000 (13.60%)

-$45,596,000 (-929.77%)

$5,495,000 (148.70%)

Enterprise Value (EV)

$247,567,277 (-58.64%)

$598,568,706 (35.03%)

$443,277,223 (-28.48%)

$619,799,694 (10.40%)

Earnings Before Tax (EBT)

-$44,464,000 (11.62%)

-$50,310,000 (-6.21%)

-$47,368,000 (-3.30%)

-$45,856,000 (-27.23%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$43,871,000 (8.02%)

-$47,696,000 (-1.82%)

-$46,843,000 (-3.19%)

-$45,393,000 (-28.80%)

Invested Capital

$54,896,000 (287.41%)

$14,170,000 (17.65%)

$12,044,000 (109390.91%)

$11,000 (-99.96%)

Working Capital

$170,544,000 (169.63%)

$63,252,000 (45.30%)

$43,533,000 (-38.83%)

$71,166,000 (40.02%)

Tangible Asset Value

$192,931,000 (125.13%)

$85,698,000 (-3.01%)

$88,357,000 (-0.25%)

$88,578,000 (13.81%)

Market Capitalization

$324,834,777 (-51.64%)

$671,689,956 (22.71%)

$547,367,921 (-23.44%)

$714,917,027 (24.40%)

Average Equity

$69,908,000 (324.37%)

$16,473,500 (18.83%)

$13,863,250 (57.67%)

$8,792,500 (-41.32%)

Average Assets

$223,283,125 (142.39%)

$92,118,250 (-5.74%)

$97,727,750 (7.30%)

$91,082,500 (37.95%)

Invested Capital Average

$74,894,312 (300.39%)

$18,705,500 (250.29%)

$5,340,000 (-57.55%)

$12,578,500 (-38.06%)

Shares

141,644,488 (22.10%)

116,009,788 (7.74%)

107,680,012 (19.94%)

89,777,000 (14.55%)